NCT05035407 2025-12-02
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
Clinical Trials
8 trialsNCT03482557 2025-01-09
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
Beth Israel Deaconess Medical Center
Phase NA Completed
NCT02317783 2024-11-20
Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment
University of Utah
Phase 2 Terminated
NCT03750240 2022-08-24
Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy
NYU Langone Health
Phase NA Terminated
NCT02581839 2020-07-30
Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Case Comprehensive Cancer Center
Phase 2 Completed
NCT01156987 2017-03-09
Improved Breast MRI With SWIFT
University of Minnesota
Phase NA Completed
NCT01249157 2015-12-24
Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast
Memorial Sloan Kettering Cancer Center
Phase NA Terminated
NCT01012440 2015-07-27
Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer
University of Chicago
Phase NA Terminated